Board of Advisors
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to make our mission and model possible.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
NEW YORK BOARD OF ADVISORS
Michael Aberman
General Partner – Regeneron Ventures
Robin Abrams
Founder and Principal – Point Jetty Consulting LLC
Vineet Agarwal
Chief Financial Officer – Korro Bio
Sandip Agarwala
Managing Director – Blue Owl Capital
Michael Annunziata
Managing Director – Donnelley Financial SolutionsMichael Annunziata is the Managing Director at Donnelley Financial Solutions, the largest SEC Filing agent in Life Sciences. Michael is devoted to serving clients in the life sciences industry with accounting software, financial reporting solutions, SEC registration statements management, initial public offerings, and data rooms related to mergers and acquisitions and transaction support. Michael’s +25-year background ranges from life science start-ups to commercial-stage companies, managing their fundraisers, crossovers, licensing agreements, and clinical trial data support. Pre/Post IPO companies rely on Michael and his team for their deal preparations expertise at various stages of growth. Michael looks forward to supporting the goals of LSC to address both immediate and long term needs of individuals living in poverty.
Samuel Bakhoum
Chief Scientific Officer and Co-founder – Volastra Therapeutics
Christophe Beauduin
Special Counsel – Cooley
Laurence Blumberg
Biotechnology Executive
Laurence Blumberg
Biotechnology Executive
Valerie Bowling
Executive Director – The Conference Forum
Lola Brown
Associate Dean for Research – Weill Cornell Medicine
Geoff Brzuchalski
Partner – PwC
Alexandra Cantley
Partner – Polaris Partners
Kyle Carver
Chief Financial Officer – Evommune
Cara Cassino
President – Stony Point Life Sciences Consulting LLC
Kerry Clem
CCO – Solaxa
Ashish Contractor
Managing Director – Moelis & Company
Sue Crinnion
Managing Director, Life Sciences Venture Banking – Banc of California
Bryan Czyzewski
Managing Director – Jefferies
Guilerme (Will) Debarros
Northeast Life Sciences & Technology Practice Leader – Marsh McLennan Agency
Zandy Forbes
CEO – MeiraGTx
Martin Friedman
Managing Member – Pharmakon Advisors
Anjali Ganguli
Chief Business Officer – Syndax Pharmaceuticals
Dalya Gayed
Vice President, WW Hematology Strategy, Business Development and Early Assets
Bristol Myers Squibb
Dalya Gayed
Vice President, WW Hematology Strategy, Business Development and Early Assets – Bristol Myers Squibb
Matthew Gline
CEO – Roivant Sciences
Dan Gold
President – Fairway Consulting Group
Adam Golden
Partner, Global Head of Life Sciences – Freshfields
Lee Golodny
Managing Director – ZRG
Carl Gordon
Managing Partner – OrbiMed
Ruby Grewal
Executive in Residence – Roivant
Johanna Grossman
Head of Healthcare & Life Sciences, Capital Markets – New York Stock Exchange
Div Gupta
Partner – Cooley LLP
Bill Hartman
Vice Chairman – CBRE, Inc
Bill Harvey
Executive Vice President – JLL
Jennifer Hawks Bland
CEO – NewYorkBIO
Jane Henderson
Chief Financial Officer – Apogee Therapeutics
Laurent Hermouet
Partner – Athyrium
Michael Hirsch
Executive Director – Heron Therapeutics
William Holodnak
Chief Executive Officer & Founder – Occam Global
Christopher Holterhoff
Biotech Business & Corporate Development/Finance – Consultant
Colleen Tracy James
Partner – Cahill Gordon & Reindel LLP
Michael Jiang
Senior Managing Director – Guggenheim Securities
Bj Jones
Chief Commercial Officer – NewAmsterdam Pharma
Darren Jones
Partner – Baker Tilly
Patrick Jordan
Chairman – World Orphan Drug Alliance (WODA)
Rashida Karmali
CEO & President – Tactical Therapeutics, Inc
Daphne Karydas
President and CFO – Flare Therapeutics
Dr. Grace Kim
Chief Strategy Officer – Multiple Biopharma Companies
Cristina Larkin
CEO – CLC Insights LLC
Matthew Leskowitz
Managing Director – Goldman Sachs
David Longo
CEO – Ordaos Bio
Michael Margolis
Senior Managing Director – Oppenheimer & Co. Inc.
Nicole McKnight
COO – Anergent Pharmaceuticals Inc.
Rachel Mears
Investor/Partner – Jeito Capital
Scott Metzner
Founder & Principal – Janus Property
Rose Mistri Somers
Managing Director – Russell Reynolds Associates
Josh Muntner
Chief Financial Officer – Imvax, Inc.
Frank Nestola
Founding Partner – Coefficient Health
Edwin O'Connor
Partner – Goodwin
Tim Opler
CEO – Emerald Bioventures
Maria Luisa Pineda
CEO, Cofounder – Envisagenics, Inc.
Shirly Pinto
Chief Scientific Officer – Kallyope
Andrea Rabney
President and CEO – Argot Partners
Alan S. Roemer
Board Chair & Member – Various Biotechnology Companies
Eric Schmidt
Analyst – Cantor Fitzgerald
Paul J Sekhri
President & CEO – vTv Therapeutics LLC
Jesse Shefferman
CEO – Protara Therapeutics, Inc.
Michael Shih
CEO – NeoPhore Ltd.
Brian Skorney
Managing Director – Baird
Susan Snyder
Managing Partner – Wittkieffer
Tara Spiess Restieri
Chief Operating Officer – Nouveau BioSciences
Bernadette Spina Tiso
Vice President, Deputy General Counsel & Assistant Secretary to the Board of Trustees
New York Blood Center
Bernadette Spina Tiso
Vice President, Deputy General Counsel & Assistant Secretary to the Board of Trustees – New York Blood Center
Lilian Stern
Principal – Stern Investor Relations
Arthur Stril
Chief Business Officer – Cellectis
Arthur Tinkelenberg
Principal Owner – OurPlanet LLC
Ellen Travers
Partner – Chartwell Partners
Richard Truesdell
Partner – David Polk & Wardwell LLP
Frank Truslow
SVP, Corporate Development – Karuna Therapeutics
Kenan Turnacioglu
Chair of Board of Directors – Paige
Ben van der Schaaf
Partner – Arthur D. Little
Allen Waxman
Of Counsel – DLA Piper
Joe Wolfe
National Life Sciences Business Development Leader – RSM
Alethia Young
CFO – Bicycle Therapeutics